The ErbB Receptors and their Ligands in Cancer: An Overview

E-ISSN： 1873-5592|6|3|243-257

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.3, 2005-05, pp. : 243-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting ErbB Receptors in High-Grade Glioma

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2468-2487

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM proteases, ErbB pathways and cancer

By Zhou Bin-Bing S Fridman Jordan S Liu Xiangdong Friedman Steve M Newton Robert C Scherle Peggy A

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 591-606

Informa Healthcare

Access to resources Recommend Favorite

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

Current Cancer Drug Targets, Vol. 14, Iss. 9, 2014-11 ,pp. : 775-793

Bentham Science Publishers

Access to resources Recommend Favorite

Transactivation of ErbB Receptors by Leptin in the Cardiovascular System: Mechanisms, Consequences and Target for Therapy

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 616-624

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of erbB-1 kinase

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1903-1907

Informa Healthcare

Access to resources Recommend Favorite